The Marked Chart Wire · Business
Novartis
Novartis lifts peak revenue outlook for key therapies
The pharmaceutical company raised its long-term sales targets for its top-selling treatments to $18 billion, citing robust market demand for its core products.
Part of a series: Novartis lifts profit outlook and sales targets
